CIPO Patents = 2

EPO Patents = 1

Forward Citations = 65

Loading Chart...

6 inventors (with patents filed for the assignee):

J Andrew Bristol (3 out of 16 patents)

Myron Arlen (2 out of 15 patents)

Kwong Y Tsang (2 out of 18 patents)

4. Judith A Kantor (1 out of 18 patents)

5. Ariel C Hollinshead (1 out of 7 patents)

6. Ariel C Hollnshead (1 out of 1 patent)

7. Mark Semenuk (0 patent)

8. Lewis Joe Stafford (0 patent)

3 patents: Sort by Forward Citations

1. 7829678 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers (2010-11-09),

2. 7763720 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers (2010-07-27),

3. 7314622 - Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers (2008-01-01),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#150 in Rockville, MD

#1,106 in Maryland

#73,860 in US

Rockville, MD, United States of America

Neogenix Oncology, Inc.

Forward Citations = 65

6 inventors:

J Andrew Bristol (3 out of 16 patents)

Myron Arlen (2 out of 15 patents)

Kwong Y Tsang (2 out of 18 patents)

4. Judith A Kantor (1 out of 18 patents)

5. Ariel C Hollinshead (1 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neogenix Oncology, Inc.. Retrieved from https://idiyas.com/company/neogenix-oncology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]